HUABIO Blog
Broad Researcher’s Find SETDB1 Helps Tumors Evade the Immune System
SETDB1 could be targeted by new drugs for cancer patients who don’t respond to existing immunotherapies.
Publication Spotlight: RNA Binding Protein FgRbp1 Regulates Specific Pre-mRNA Splicing in Fusarium
In the recent publication by Wang et al. HUABIO’s anti-RPS3 antibody and anti-RPS20 antibody helped determine if FgRbp1 is a splicing regulator and regulates the pre-mRNA splicing in a sequence-dependent manner in F. graminearum.
HUABIO Announces New French Distributor
HUABIO is partnering with Euromedex to provide French researchers the very best life science products.
Since 1984, Eu...
Nanobodies in the News
Tick-borne bacterial infection blocked by nanobodies
Breakthrough Discovery of a New T-Cell Lineage
Introducing γμ T cells
Earth Day, Every Day
Earth Day is all about empowering people with the information, the tools, the messaging needed to make an impact and drive environmental change.
New Advances in Regenerative Medicine Using Zebrafish
Zebrafish regenerative protein could inspire new treatments for muscle wasting
Publication Spotlight: Innovative Dissolvable Microneedle Patches are an Effective Treatment of Inflammatory Skin Disorders
Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders.
How to Choose a Loading Control for Western Blotting
Loading controls serve as a vital method of verifying the results acquired through western blotting by normalizing...
Nanobodies in the News
Novel nanobody used to study the dynamics of microtubules
Brain Aging Accelerated with Loss of p53 Isoform
Depletion of Δ113p53/Δ133p53 may result in long-term ROS stress and finally lead to age-related diseases, such as AD and ALS in humans.
TEST! TEST! TEST!
Is this blog on? Try out new HUABIO test sized antibodies!